Aurobindo Pharma gets final approval for Abacavir Sulfate and Lamivudine Tablets

From USFDA

Aurobindo Pharma announced that the Company has received final approval from the US Food & Drugs Administration to manufacture Abacavir Sulfate and Lamivudine Tablets, 600 mg/ 300 mg. Aurobindo's Abacavir Sulfate and Lamivudine Tablets are the AB rated generic equivalent of VIIV Healthcare Company's Epzicom Tablets. The product is being launched immediately.

Powered by Capital Market - Live News